Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

| More on:
Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Aristocrat Leisure Limited (ASX: ALL)

Analysts at Morgans have retained their add rating on this gaming technology company's shares with a significantly improved price target of $67.00. The broker has increased its valuation after updating its earnings forecasts to reflect strong industry data and feedback. Morgans highlights that the company's iGaming business is outperforming expectations and believes that its digital business, Pixel United, is performing to expectations. This is a positive for investors given recent trends from this side of its business. The Aristocrat share price is trading at $62.12 on Monday.

CSL Ltd (ASX: CSL)

According to a note out of Citi, its analysts have retained their buy rating and $345.00 price target on this biotechnology company's shares. The broker highlights that rival Takeda Pharmaceutical Co Ltd (NYSE: TAK) has just released its quarterly update and revealed a strong increase in immunoglobulin products revenue over the prior corresponding period. Citi notes that this performance was in line with its expectations and believes it bodes well for CSL's performance during the first half of FY 2025. In fact, it feels that Takeda's quarter supports its view that CSL will outperform the market's expectations for immunoglobulin and albumin sales during the half. In light of this, it continues to rate CSL as a buy and sees plenty of value in its shares at current levels. The CSL share price is fetching $284.89 at the time of writing.

Nickel Industries Ltd (ASX: NIC)

A note out of Bell Potter reveals that its analysts have retained their buy rating on this nickel producer's shares with a trimmed price target of $1.43. This follows the release of Nickel Industries' quarterly update. Overall, Bell Potter believes this was a positive quarter with nickel pig iron (NPI) production down marginally on prior quarters but offset by increased production of higher margin Mixed Hydroxide Precipitate. Outside this, the broker likes Nickel Industries because it is one of the world's largest listed nickel producers and offers exposure across a range of nickel products and markets. It also notes that the company offers attractive production and margin growth in 2025, unfranked dividends, and trades on undemanding forward valuation multiples. The Nickel Industries share price is trading at 91.7 cents at the time of writing.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three happy construction workers on an infrastructure site have a chat.
Resources Shares

3 ASX lithium stocks primed for an electric performance: Macquarie

Time to charge up?

Read more »

Three happy multi-ethnic business colleagues discuss investment or finance possibilities in an office.
Broker Notes

ASX financial shares are up 33% this year. Brokers reveal which stocks to buy for 2025

After such a stellar run, are there any good buys left among ASX financial shares?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Broker Notes

3 reasons to buy this ASX 200 stock now

Bell Potter thinks investors should be snapping up this stock right now.

Read more »

A smiling young surf life saver at the beach shouts out on a megaphone.
Broker Notes

2 ASX 200 shares to buy that this fund manager is bullish about

These stocks could be exciting blue-chip picks right now.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

2 ASX healthcare small-cap shares to buy now: brokers

These 2 small-cap healthcare companies have captured the attention of experts.

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Energy Shares

Top broker says Boss Energy shares have 29% upside

Nuclear energy continues to be an emerging theme for investors.

Read more »

Broker looking at the share price.
Broker Notes

Here's the latest broker upgrades on ASX All Ords shares

Let's dive in.

Read more »